Nutrinia is a neonatology company developing pharmaceuticals to treat rare conditions of the gastrointestinal tract. Our current products in development are oral formulations of insulin shown to enhance adaptation and rehabilitation of the gut in infants. We at Nutrinia live by the belief that science is best used to make life better for people, especially the most vulnerable populations.
Tal received his B.Pharm magna cum laude from The School of Pharmacy at Hebrew University of Jerusalem, and M.Sc. in Bioinformatics at the interdisciplinary program of The Weizmann Institute of Science.